For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Publications

Found 80 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
Journal Article
Molina AM, van der Mijn JC, Christos P, Wright J, Thomas C, Dutcher JP, Nanus DM, Tagawa ST, Gudas LJ.  2020.  NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.. Invest New Drugs.
Turchioe MReading, Grossman LV, Baik D, Lee CS, Maurer MS, Goyal P, Safford MM, Creber RMMasterso.  2020.  Older Adults Can Successfully Monitor Symptoms Using an Inclusively Designed Mobile Application.. J Am Geriatr Soc.
Mullangi S, Bhandari R, Thanaporn P, Christensen M, Kronick S, Nallamothu BK.  2020.  Perceptions of resuscitation care among in-hospital cardiac arrest responders: a qualitative analysis.. BMC Health Serv Res. 20(1):145.
Pesko MF, Xu X, Tynan MA, Gerzoff RB, Malarcher AM, Pechacek TF.  2014.  Per-pack price reductions available from different cigarette purchasing strategies: United States, 2009-2010.. Prev Med. 63:13-9.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
DeLia D, Tong J, Gaboda D, Casalino LP.  2014.  Post-discharge follow-up visits and hospital utilization by Medicare patients, 2007-2010.. Medicare Medicaid Res Rev. 4(2)
Bao Y, Pan Y, Taylor A, Radakrishnan S, Luo F, Pincus HAlan, Schackman BR.  2016.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.. Health Aff (Millwood). 35(6):1045-51.
Anderson MR, Tabah A, RoyChoudhury A, Lederer DJ.  2019.  Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study.. Ann Am Thorac Soc. 16(2):231-239.
Frey MK, Kahn RM, Chapman-Davis E, Tubito F, Pires M, Christos P, Anderson S, Mukherjee S, Jordan B, Blank SV et al..  2020.  Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.. J Clin Oncol. 38(13):1389-1397.
Xie Y, Valdimarsdóttir UA, Wang C, Zhong XR, Gou Q, Zheng H, Deng L, He P, Hu K, Fall K et al..  2020.  Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.. Int J Cancer.
Bond AM, Volpp KG, Emanuel EJ, Caldarella K, Hodlofski A, Sacks L, Patel P, Sokol K, Vittore S, Calgano D et al..  2019.  Real-time Feedback in Pay-for-Performance: Does More Information Lead to Improvement? J Gen Intern Med.
Tran B, Sedrakyan A, Flynn P, Altorki N, Jorm L, Wright G.  2019.  Reintervention and Survival After Limited Lung Resection for Lung Cancer Treatment in Australia.. Ann Thorac Surg. 107(5):1507-1514.
Bao Y, Tang Y, Donohue J.  2015.  Retaining Part D's comprehensive coverage of antidepressants: not a silver bullet.. JAMA Psychiatry. 72(3):201-2.
Venkatesan T, Levinthal DJ, Li BUK, Tarbell SE, Adams KA, Issenman RM, Sarosiek I, Jaradeh SS, Sharaf RN, Sultan S et al..  2019.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.. Neurogastroenterol Motil. 31 Suppl 2:e13606.
Ezeomah C, Adoga A, Ihekweazu C, Paessler S, Cisneros I, Tomori O, Walker D.  2019.  Sequelae of Lassa Fever: Postviral Cerebellar Ataxia.. Open Forum Infect Dis. 6(12):ofz512.
Caceres BA, Turchioe MReading, Pho A, Koleck TA, Creber RMasterson, Bakken SB.  2020.  Sexual Identity and Racial/Ethnic Differences in Awareness of Heart Attack and Stroke Symptoms: Findings From the National Health Interview Survey.. Am J Health Promot. :890117120932471.
McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, Weinstein ZM, Billings J, Davis NJ, Marcello RKalyanaram et al..  2019.  Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.. Addict Sci Clin Pract. 14(1):5.
Turchioe MReading, Myers A, Isaac S, Baik D, Grossman LV, Ancker JS, Creber RMasterson.  2019.  A Systematic Review of Patient-Facing Visualizations of Personal Health Data.. Appl Clin Inform. 10(4):751-770.
Dichter JR, Kanter RK, Dries D, Luyckx V, Lim ML, Wilgis J, Anderson MR, Sarani B, Hupert N, Mutter R et al..  2014.  System-level planning, coordination, and communication: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.. Chest. 146(4 Suppl):e87S-e102S.
Dichter JR, Kanter RK, Dries D, Luyckx V, Lim ML, Wilgis J, Anderson MR, Sarani B, Hupert N, Mutter R et al..  2014.  System-level planning, coordination, and communication: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.. Chest. 146(4 Suppl):e87S-e102S.
Edwards TL, Giri A, Hellwege JN, Hartmann KE, Stewart EA, Jeff JM, Bray MJ, Pendergrass SA, Torstenson ES, Keaton JM et al..  2019.  A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids.. Front Genet. 10:511.
Edwards TL, Giri A, Hellwege JN, Hartmann KE, Stewart EA, Jeff JM, Bray MJ, Pendergrass SA, Torstenson ES, Keaton JM et al..  2019.  A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids.. Front Genet. 10:511.